Latest news
Press releases
Jan 15, 2026, 10:15
News
IR
English
Corporate Action
Other
mfn-ext-nq
mfn-ext-nq-corporate-action
Jan 15, 2026, 10:15
News
IR
Swedish
Corporate Action
Other
mfn-ext-nq
mfn-ext-nq-corporate-action
Jan 13, 2026, 13:40
News
IR
English
Corporate Action
Other
mfn-ext-nq
mfn-ext-nq-corporate-action
Jan 13, 2026, 13:40
News
IR
Swedish
Corporate Action
Other
mfn-ext-nq
mfn-ext-nq-corporate-action
Dec 22, 2025, 10:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-listing
Dec 22, 2025, 10:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-listing
Dec 16, 2025, 12:45
News
IR
English
Regulatory
Listing Regulation
Corporate Action
Other
mfn-cus-disclaimer
mfn-cus-top-disclaimer
mfn-ext-nq
mfn-ext-nq-corporate-action
Dec 16, 2025, 12:45
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Action
Other
mfn-cus-disclaimer
mfn-cus-top-disclaimer
mfn-ext-nq
mfn-ext-nq-corporate-action
Dec 15, 2025, 10:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Raport bolagsstämman
Nov 25, 2025, 21:15
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Nov 25, 2025, 21:05
News
IR
Swedish
Regulatory
MAR
Corporate Action
Other
mfn-cus-top-disclaimer
mfn-ext-nq
mfn-ext-nq-corporate-action
Nov 25, 2025, 21:05
News
IR
English
Regulatory
MAR
Corporate Action
Other
mfn-cus-top-disclaimer
mfn-ext-nq
mfn-ext-nq-corporate-action
Oct 31, 2025, 09:35
News
IR
English
Regulatory
MAR
Corporate Information
Staff change
Oct 14, 2025, 15:37
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-inside-information
Oct 14, 2025, 15:37
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-inside-information
Aug 13, 2025, 16:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-listing
Aug 13, 2025, 16:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-listing
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
Interim CEO
Anders Månsson
Mail: anders.mansson@iconovo.se